Synthical
Your space
Profile
Activity
Favorites
Folders
Feeds
All articles
Claim page
M. Dankner
Follow
Activity
Upvotes
Folders
Articles
2
Clinical activity of Mitogen-Activated Protein Kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers
27 January 2025 by
M. Dankner
and
others
Oncology
The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers
19 January 2024 by
S. Kazandjian
and
others
Cancer Biology
Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors
17 August 2022 by
M. Dankner
and
others
Oncology
This is an AI-generated summary
Key points
Topics
Cancer Biology
Oncology
